Claudio Ronco
Director of the International Renal Research Institute of Vicenza (IRRIV)
C/O Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy
Talk
Engineering the artificial kidney: memories of a translational research journey and future challenges Recording available here
Short Bio
Claudio Ronco (Full Professor by “clara fama” of Nephrology at the University of Padova from 2018 to 2021) is the Director of the International Renal Research Institute (IRRIV) at the Department of Nephrology Dialysis and Transplantation (San Bortolo Hospital, Vicenza). He graduated in Medicine in 1976 and specialised in Nephrology in 1979 at the University of Padua. He has been the Director of the Laboratory of the Renal Research Institute at the Mount Sinai Beth Israel (New York) and Professor of Medicine at the Albert Einstein College of Medicine (New York). He is external professor at the University of Virginia of Charlottesville and the University Fudan and Jiao Tong University in Shanghai. He received the Honorary degree at the University of Patras. He authored 1734 papers, 95 books and 195 book chapters and delivered more than 1250 lectures at international meetings. His H-index is 137. He is the Editor-in-Chief of Blood Purification, Contributions to Nephrology, Cardiorenal Medicine and Editor emeritus of the International Journal of Artificial Organs. He has received several international awards. He is considered the pioneer in many areas of nephrology including peritoneal dialysis, critical care nephrology, CRRT, hemoperfusion, cardiorenal syndromes and wearable dialysis technology. He invented the first CRRT machine for neonates (CARPEDIEM, Cardio Renal Pediatric Dialysis Emergency Machine).
Paolo Antonio Netti
Professor of Industrial Bioengineering, University of Naples Federico II
President of GNB
Talk
from bioENGINEERING to BIOENGINEERING: where a 40 years long journey is heading to? Recording available here
Short Bio
Paolo A. Netti obtained a degree in Chemical Engineering in 1990 and a Ph.D. in Chemical Engineering in 1994 at the University of Naples "Federico II". He subsequently carried out research at the IRC in the Biomedical Materials of the University of London and at the Health Science and Technology Institute of Harvard University in Boston. Since 2000 he has been teaching and conducting research at the University of Naples "Federico II" where he is now a full professor of bioengineering. His scientific interests are in the field of biomaterials for health care, for tissue regeneration and tissue engineering, for nanomedicine in therapy and diagnostics and for advanced sensors. He is known in the international scientific community for having contributed to enriching and expanding the modern concept of biomaterial and extending the boundaries of the application to ever wider sectors of biomedical areas. He has been co-founder and director of the Interdepartmental Center for Research on Biomaterials (CRIB) of Federico II University (2004 – 2010); Chair of the Master's Degree in Materials Engineering from 2005 to 2013; Founder and chair the Master's Degree in Industrial Bioengineering since 2015; Founder and director of the Center for Advanced Biomaterials for Health Care (IIT @ CRIB) of the Italian Institute of Technology since 2009; Member of the scientific panels of the European commission for the definition of the roadmap for the development of new platforms on biomaterials (VII framework program); since 2009 he has been a member of the advanced grants evaluation committee of the European Research Council (ERC) and from 2015 to 2018 he has been the Chair of the PE5 panel of the Advanced Grants; he has been scientific tutor for some MIUR research platforms (FIRB 2012); the promoter of a program to create a national network of tissue engineering laboratories (FIRB-TISSUENET), and component of the panel of experts for the preparation of the Italian Research Program (PNR) 2020-2026. He has published over 450 scientific papers accumulating over 15,000 citations, over 30 book chapters, and has filed over 30 patents.